A complete guide to EU drug approval procedures
- Registration open until 21 April 2026 -
Webcode 26042610
22/04/2026
22/04/2026
from 09:00 -17:00
You may dial-in 30 minutes before
online
online
Event - 1,290€ plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Event - 1,290€ plus tax
The participation fee includes downloadable documentation, a certificate, access to the Learning Space and technical support including PreMeeting.
Jean-Marie Bayhurst
Conference Manager
+49 6221 500-685
j.bayhurst@forum-institut.de
- Registration open until 21 April 2026. Remaining places subject to availability. - This seminar provides an in-depth exploration of EU drug marketing authorisation, focusing on regulatory frameworks, application types and procedures. It covers mutual recognition, decentralised and centralised procedures (MRP, DCP, CP) in detail, providing essential insights for successful EU drug approval.
This seminar provides a comprehensive understanding of EU drug marketing authorisation procedures.
Participants will explore the regulatory framework, various application types, and detailed application procedures, gaining essential insights into navigating EU drug approval complexities.
